VELA Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-8,507
| Closed | -$3.46M | – | 157 |
|
2023
Q4 | $3.46M | Sell |
8,507
-628
| -7% | -$256K | 1.32% | 16 |
|
2023
Q3 | $3.18M | Buy |
9,135
+278
| +3% | +$96.7K | 1.4% | 17 |
|
2023
Q2 | $3.12M | Sell |
8,857
-826
| -9% | -$291K | 1.44% | 14 |
|
2023
Q1 | $3.05M | Buy |
9,683
+846
| +10% | +$267K | 1.39% | 16 |
|
2022
Q4 | $2.55M | Buy |
8,837
+34
| +0.4% | +$9.82K | 1.26% | 20 |
|
2022
Q3 | $2.55M | Sell |
8,803
-472
| -5% | -$137K | 1.45% | 19 |
|
2022
Q2 | $2.61M | Buy |
9,275
+905
| +11% | +$255K | 1.5% | 18 |
|
2022
Q1 | $2.18M | Buy |
8,370
+790
| +10% | +$206K | 1.37% | 23 |
|
2021
Q4 | $1.67M | Buy |
+7,580
| New | +$1.67M | 1.12% | 28 |
|